Comparison of glycated albumin and hemoglobin A1c levels in diabetic subjects on hemodialysis

Glycated albumin is thought to more accurately reflect glycemic control in diabetic hemodialysis patients than hemoglobin A1c because of shortened red cell survival. To test this, glycated hemoglobin and albumin levels were measured in blood samples collected from 307 diabetic subjects of whom 258 w...

Full description

Saved in:
Bibliographic Details
Published in:Kidney international 2008-05, Vol.73 (9), p.1062-1068
Main Authors: Peacock, T.P., Shihabi, Z.K., Bleyer, A.J., Dolbare, E.L., Byers, J.R., Knovich, M.A., Calles-Escandon, J., Russell, G.B., Freedman, B.I.
Format: Article
Language:English
Subjects:
Biological and medical sciences
diabetes mellitus
Diabetes. Impaired glucose tolerance
end-stage renal disease
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Etiopathogenesis. Screening. Investigations. Target tissue resistance
glycated albumin
glycemic control
hemodialysis
hemoglobin A1c
Medical sciences
Nephrology. Urinary tract diseases
Nephropathies. Renovascular diseases. Renal failure
Renal failure
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Glycated albumin is thought to more accurately reflect glycemic control in diabetic hemodialysis patients than hemoglobin A1c because of shortened red cell survival. To test this, glycated hemoglobin and albumin levels were measured in blood samples collected from 307 diabetic subjects of whom 258 were on hemodialysis and 49 were without overt renal disease. In diabetic subjects with renal disease, relative to those without, the mean serum glucose and glycated albumin concentrations were significantly higher while hemoglobin A1c tended to be lower. The glycated albumin to hemoglobin A1c ratio was significantly increased in dialysis patients compared with the controls. Hemoglobin A1c was positively associated with hemoglobin and negatively associated with the erythropoietin dose in hemodialysis patients, whereas these factors and serum albumin did not significantly impact glycated albumin levels. Using best-fit multivariate models, dialysis status significantly impacted hemoglobin A1c levels without a significant effect on glycated albumin. Our results show that in diabetic hemodialysis patients, hemoglobin A1c levels significantly underestimate glycemic control while those of glycated albumin more accurately reflect this control.
ISSN:0085-2538
1523-1755
DOI:10.1038/ki.2008.25